Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Wisconsin, Madison
ALX Oncology Inc.
Rutgers, The State University of New Jersey
Actuate Therapeutics Inc.
Ambrx, Inc.
Dana-Farber Cancer Institute
Institut Curie
Icahn School of Medicine at Mount Sinai
Wake Forest University Health Sciences
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Regeneron Pharmaceuticals
GBG Forschungs GmbH
The Netherlands Cancer Institute
Tempus AI
Institut Bergonié
UNICANCER
MedSIR
Daiichi Sankyo
MedSIR
MedSIR
Massachusetts General Hospital
Stony Brook University
Elevation Oncology
Queen Mary University of London
The Netherlands Cancer Institute
NantCell, Inc.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Dartmouth-Hitchcock Medical Center
Queen Mary University of London
ETOP IBCSG Partners Foundation
ETOP IBCSG Partners Foundation
Fudan University
pharmaand GmbH
Georgetown University
Massachusetts General Hospital
OncoSec Medical Incorporated
iOMEDICO AG
Universitaire Ziekenhuizen KU Leuven
Duke University
National Institutes of Health Clinical Center (CC)
Fudan University
The Netherlands Cancer Institute
Fudan University
Medstar Health Research Institute
Shanghai Jiao Tong University School of Medicine
G1 Therapeutics, Inc.
The Netherlands Cancer Institute
The Netherlands Cancer Institute